Clinical trial
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
NCT00346866 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00346866 |
|---|---|
| Title | Anecortave Acetate Versus Placebo in AMD Patients Following PDT |
| Official title | Anecortave Acetate Versus Placebo in AMD Patients Following PDT |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AMD |
| Intervention type | Drug |
| Interventions | anecortave acetate |
| Enrollment | 136 |
| Start date | May 1, 2000 |
| Primary completion | Dec 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Jun 30, 2006 |
| Last update posted | Aug 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: